Insider Trading May 4, 2026 05:04 PM

Vita Coco Executive Executes Rule 10b5-1 Stock Sale Amid Strong Fiscal Performance

Chief Commercial Officer Charles van Es disposes of 2,000 shares as company reports significant Q1 revenue and income beats.

By Derek Hwang COCO
Vita Coco Executive Executes Rule 10b5-1 Stock Sale Amid Strong Fiscal Performance
COCO

Charles van Es, the Chief Commercial Officer of Vita Coco Company, Inc. (NASDAQ: COCO), has completed a sale of common stock valued at $133,740. The transaction occurred on May 1, 2026, as part of a predetermined trading plan. This insider activity comes against a backdrop of significant recent financial growth for the beverage company, which reported first-quarter fiscal 2026 results that outperformed market expectations across several key metrics, including revenue, net income, and adjusted EBITDA.

Key Points

  • Vita Coco reported Q1 fiscal 2026 sales of $180 million, a 37% year-over-year increase, beating analyst estimates.
  • Net income of $0.50 per diluted share exceeded the forecasted $0.315 per share.
  • Adjusted EBITDA reached $38.7 million, significantly higher than the expected $26.0 million.

Charles van Es, serving as the Chief Commercial Officer for Vita Coco Company, Inc. (NASDAQ: COCO), recently executed a transaction involving the sale of company shares. On May 1, 2026, Mr. van Es sold 2,000 shares of common stock at a price per share of $66.87. This specific transaction resulted in a total value of $133,740.

The sale was conducted under the framework of a Rule 10b5-1 trading plan. Such plans are utilized by corporate insiders to establish a pre-set schedule for the buying or selling of shares, a mechanism designed to mitigate concerns regarding potential insider trading by automating the timing of transactions.

Following this divestment, Mr. van Es maintains a direct holding of 75,691 shares of Vita Coco common stock. Beyond these direct holdings, he possesses various non-qualified stock options that grant him the right to purchase a total of 232,267 shares of common stock. The exercise prices for these options range from $10.178 to $33.36. The availability of these options varies: some are fully vested and ready for immediate exercise, while others are subject to annual vesting schedules or specific performance-based conditions.

The transaction took place as the stock has experienced significant upward momentum, trading at $67.27 recently and reflecting a 95% increase over the preceding year. The company currently holds a market valuation of $3.81 billion and carries a P/E ratio of 47.77. Analysis from InvestingPro indicates that the stock is currently priced above its calculated Fair Value.


Key Financial and Operational Highlights

The insider sale follows a period of robust financial reporting from Vita Coco. For the first quarter of fiscal 2026, the company posted sales of $180 million, which represents a 37% increase compared to the same period last year. This revenue figure was notably higher than the $149.6 million anticipated by BofA Securities and the $149.2 million consensus from Visible Alpha.

  • Earnings Outperformance: Net income for the quarter reached $30 million, or $0.50 per diluted share, which surpassed the forecasted amount of $0.315 per share.
  • EBITDA Strength: Adjusted EBITDA was reported at $38.7 million, exceeding the Street expectation of $26.0 million.
  • Analyst Sentiment: In light of these results, BofA Securities increased its price target for COCO to $72 while maintaining a Buy rating. Similarly, Evercore ISI raised its price target from $70 to $75 and kept an Outperform rating.

Market Impacts and Risk Factors

Key Points and Sector Impact:
The strong quarterly performance in revenue and profitability highlights Vita Coco's ability to execute within the consumer goods sector. The substantial beat on EBITDA and net income suggests operational efficiency that impacts investor sentiment in the beverage and specialty food markets. The upward revisions of price targets by major institutions like BofA Securities and Evercore ISI indicate continued institutional interest in the company's growth trajectory.

Risks and Uncertainties:
Despite recent gains, there are notable risks for investors to consider:

  • Valuation Concerns: With a P/E ratio of 47.77 and InvestingPro analysis suggesting the stock is overvalued relative to its Fair Value, there is an inherent risk regarding price corrections in the consumer staples sector.
  • Market Volatility: While the stock has seen a 95% gain over the last year, maintaining this momentum depends on continued ability to exceed high market expectations for revenue and earnings.

Risks

  • The stock is currently viewed as overvalued relative to its Fair Value according to InvestingPro analysis.
  • High P/E ratio of 47.77 may present valuation risks if growth slows.

More from Insider Trading

Extreme Networks CEO Executes $1.1 Million Stock Sale Amid Recent Price Surge May 4, 2026 Glaukos Corp CFO Alex Thurman Executes $1.4 Million Stock Sale Under Pre-Arranged Plan May 4, 2026 Kimberly-Clark Executive Executes Stock Sale Amidst Complex Financial Outlook May 4, 2026 Hayward Holdings Executive Increases Stake via Employee Stock Purchase Plan May 4, 2026 Orion Group Holdings Director Executes Stock Dispositions Amid Recent Price Appreciation May 4, 2026